Disclosures for "Rare Dual Genotype IDH-Mutant Glioma: Two Cases of True “Oligoastrocytoma”")
-
Ms. Sutherland has nothing to disclose.
-
Dr. DeWitt has nothing to disclose.
-
Dr. Thomas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roon. The institution of Dr. Thomas has received research support from Novocure. The institution of Dr. Thomas has received research support from Spectrum Pharmaceuticals. The institution of Dr. Thomas has received research support from Ono Pharmaceuticals.